4.2 Article

Role of defensins in the pathogenesis of chronic lung allograft rejection

Journal

HUMAN IMMUNOLOGY
Volume 75, Issue 4, Pages 370-377

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.humimm.2013.12.014

Keywords

-

Categories

Funding

  1. NIH [HL056643, HL092514]
  2. ISHLT Research Fellowship

Ask authors/readers for more resources

Chronic rejection predominantly manifested as bronchiolitis obliterans syndrome (BUS), still remains a major problem affecting long-term outcomes in human lung transplantation (LTx). Donor specific antibodies (DSA) and infiltration of neutrophils in the graft have been associated with the development of BUS. This study determines the role of defensins, produced by neutrophils, and its interaction with alpha- 1-antitrypsin (AAT) towards induction of airway inflammation and fibrosis which are characteristic hallmarks of BUS. Bronchoalveolar lavage (BAL) and serum from LTx recipients, BOS+ (n = 28), BOS- (n = 26) and normal healthy controls (n = 24) were analyzed. Our results show that BOS+ LTx recipients had higher alpha-defensins (HNP1-3) and beta-defensin2 HBD2 concentration in BAL and serum compared to BOS-DSA-recipients and normal controls (p = 0.03). BOS+ patients had significantly lower serum AAT along with higher circulating concentration of HNP-AAT complexes in BAL (p = 0.05). Stimulation of primary small airway epithelial cells (SAECs) with HNPs induced expression of HBD2, adhesion molecules (ICAM and VCAM), cytokines (IL-6, IL-1 beta, IL-13, IL-8 and MCP-1) and growth-factor (VEGF and EGF). In contrast, anti-inflammatory cytokine, IL-10 expression decreased 2-fold (p = 0.002). HNPs mediated SAEC activation was completely abrogated by PAT. In conclusion, our results demonstrates that neutrophil secretory product, a-defensins, stimulate p-defensin production by SAECs causing upregulation of pro-inflammatory and pro-fibrotic signaling molecules. Hence, chronic stimulation of airway epithelial cells by defensins can lead to inflammation and fibrosis the central events in the development of BUS following LTx. (C) 2014 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available